At a glance
- Originator Banyu
- Class Antihypertensives
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 05 Dec 2003 No development reported - Preclinical for Hypertension in Japan (PO)
- 06 Jun 2001 New profile
- 06 Jun 2001 Preclinical development for Hypertension in Japan (PO)